Oral Argument: Mullin v. Doe

About this episode

The episode discusses the oral arguments in the case Mullin v. Doe regarding the termination of Temporary Protected Status for Syrian nationals.

Mullin v. Doe | 25-1083 | Docket Link: Here Consolidated with Trump v. Miot 25-1084 | Docket Link: Here Argument Date: 4/29/2026 Oral Advocates: Petitioners (United States): D. John Sauer, United States’ Solicitor General Respondents (Doe): Ahilan T. Arulanantham of UCLA School of Law Respondents (Miot): Geoffrey M. Pipoly of Bryan Cave Leighton Paisner LLP Question Presented: Whether 8 U.S.C. § 1254a(b)(5)(A)'s judicial review bar precludes APA challenges to the Secretary's termination of Syria's Temporary Protected Status designation, and if reviewable, whether the termination violated the APA. Overview: Emergency stay application challenges Secretary Mullin's termination of Temporary Protected Status for 6,132 Syrian nationals. Central questions: whether courts may review TPS termination decisions at all, and whether the Secretary followed required consultation and country-conditions procedures. Posture: S.D.N.Y. postponed Syria's TPS termination; Second Circuit denied stay; government now seeks Supreme Court intervention. Main Arguments: Government (Applicant): (1) Section 1254a(b)(5)(A) bars all APA challenges to TPS terminations; (2) Secretary validly consulted agencies and…

People in this episode

Guests: D. John Sauer, Ahilan T. Arulanantham, Geoffrey M. Pipoly

Topics covered

• Temporary Protected Status
• judicial review
• Supreme Court
• immigration law
• government policy

Keywords

• Mullin v. Doe
• Temporary Protected Status
• Supreme Court
• judicial review
• immigration

Mentioned in this episode

Organizations: UCLA School of Law, Bryan Cave Leighton Paisner LLP

Places: Syria

More episodes of The High Court Report

• Opinion Summary: Keathley v. Buddy Ayers | Nondisclosure Doesn't Lead to Lawsuit Dismissal · June 12, 2026 · 12 min
• Oral Argument Re-Listen: Hikma Pharmaceuticals v. Amarin Pharma | Generic Drug Beats Patent Trap · June 11, 2026 · 1h 2m
• Opinion Summary: Hikma Pharmaceuticals v. Amarin Pharma | Generic Drug Beats Patent Trap · June 10, 2026 · 1h 2m
• Oral Argument Re-Listen: Sripetch v. SEC | Victimless Fraudsters Can't Keep Profits · June 9, 2026 · 1h 12m
• Opinion Summary: Sripetch v. SEC | Victimless Fraudsters Can't Keep Profits · June 8, 2026 · 15 min
• Oral Argument Re-Listen: FCC v. AT&T | Forfeiture Fines Without Force · June 7, 2026 · 1h 26m